Company Filing History:
Years Active: 2013-2015
Title: Innovations of Inventor Sanjay Kumar Garg
Introduction
Sanjay Kumar Garg, an accomplished inventor based in Chhattisgarh, India, has made significant contributions to the field of immunology. With two patents to his name, Garg has been at the forefront of developing innovative solutions to combat bacterial infections through advanced immunoregulator compounds.
Latest Patents
Garg’s latest patents focus on sphingosine derivative compounds, such as D-erythro-sphingosine 1-phosphate (S1P), which serve as immunomodulators in the treatment of infections caused by bacteria. These unique compounds are characterized by their ability to stimulate macrophagic Phospholipase D (PLD). The inventions also include pharmaceutical compositions that incorporate these sphingosine derivatives, along with diagnostic methods for their preparation. Furthermore, the inventions outline methods to induce or restore the microbicidal activity of macrophages in vitro. This is crucial for monitoring phagocytosis efficiency and evaluating the therapeutic effectiveness of candidate microbicides.
Career Highlights
Sanjay Kumar Garg has established himself as a notable figure within the research community. He works at the University of Rome “Tor Vergata,” where he continues to innovate and contribute to the field of pharmaceuticals and immunology. His work centers on advancing medical treatment methodologies through rigorous research and innovative thinking.
Collaborations
Throughout his career, Garg has collaborated with esteemed colleagues, including Maurizio Fraziano and Antonio Ciaramella. These partnerships highlight the collaborative spirit prevalent in scientific research, enhancing the development of effective solutions through shared expertise.
Conclusion
Sanjay Kumar Garg is a pioneering inventor whose work has profound implications for the medical field, particularly in combating bacterial infections. With his innovative patents on immunoregulator compounds, he stands as a testament to how research and invention can lead to significant advancements in healthcare. His ongoing contributions at the University of Rome “Tor Vergata” affirm his commitment to improving global health outcomes through scientific innovation.